FDA Advisory Panel Recommends Cymbalta for Use to Treat Chronic Pain
Links shared publicly online about this topic.
- 921total visits
FDA Advisory Panel Recommends Cymbalta for Use to Treat Chronic Pain
Read what conditions the FDA advisory panel recommends for Cymbalta to treat.
View full resource at spine-health.com
Tags: Chronic Pain, Anxiety Medication, Antidepressant, Fibromyalgia Medication, Neuropathic Pain Medication, FDA, Cymbalta
Most Recently Shared on November 11, 2010 at 10:10 pm By:
Update: FDA has Approved Cymbalta to Use for Chronic Back Pain http://bit.ly/cuD8sU
Equivocal Message on Duloxetine for Pain from Panel - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- BETHESDA, Md. " An FDA advisory committee has voted narrowly " 8 to 6 " to recommend that the agency expand the indication for the antidepressant duloxetine (Cymbalta) to treat chronic musculoskeletal pain.” View full resource at qualitypointtech.net
Most Recently Shared on August 19, 2010 at 10:45 pm By:
Equivocal Message on Duloxetine for Pain from Panel: (MedPage Today) -- BETHESDA, Md. — An FDA advisory committe... http://bit.ly/bD6tYP
Advertisement
